Compare Ginkgo Bioworks Holdings Inc (DNA) vs MasTec Inc (MTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs MasTec Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while MasTec Inc trades at $277.54 (market cap $21.90B). The key difference: MasTec Inc is far larger — about 43.3× Ginkgo Bioworks Holdings Inc's market cap, and MasTec Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | MTZ | |
|---|---|---|
Market Cap | $505.73M | $21.90B |
Sector | Health | Technology |
52-Week High | $16.14 | $437.51 |
52-Week Low | $5.48 | $172.51 |
Enterprise Value | $607.68M | $24.81B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →
